354,339 Shares in Quanterix Corporation $QTRX Acquired by SCS Capital Management LLC

Key Points

• SCS Capital Management LLC invested approximately $2.31 million in Quanterix Corporation, acquiring 354,339 shares, which represents about 0.91% ownership of the company.
• Quanterix reported a quarterly loss of ($0.47) earnings per share, missing analyst expectations, with revenue of $24.48 million compared to estimates of $29.73 million.
• Several research firms downgraded Quanterix's stock ratings, with a current consensus target price of $11.75 and a notable decrease in Canaccord Genuity's price target from $12.00 to $5.00.

SCS Capital Management LLC acquired a new stake in Quanterix Corporation (NASDAQ:QTRX - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 354,339 shares of the company's stock, valued at approximately $2,307,000. SCS Capital Management LLC owned 0.91% of Quanterix as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. State of Wyoming purchased a new stake in shares of Quanterix during the 1st quarter worth $47,000. ProShare Advisors LLC purchased a new stake in shares of Quanterix during the 4th quarter worth $108,000. Cetera Investment Advisers purchased a new stake in shares of Quanterix during the 4th quarter worth $108,000. Quantbot Technologies LP increased its position in shares of Quanterix by 245.9% in the first quarter. Quantbot Technologies LP now owns 11,272 shares of the company's stock valued at $73,000 after buying an additional 8,013 shares in the last quarter. Finally, Aaron Wealth Advisors LLC purchased a new position in shares of Quanterix in the first quarter valued at $79,000. 86.48% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have recently weighed in on QTRX. Canaccord Genuity Group restated a "hold" rating and issued a $5.00 price target (down previously from $12.00) on shares of Quanterix in a research report on Monday, August 11th. Wall Street Zen cut Quanterix from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. One research analyst has rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $11.75.

Quanterix Price Performance

NASDAQ:QTRX traded up $0.02 during mid-day trading on Friday, reaching $4.81. The company's stock had a trading volume of 505,678 shares, compared to its average volume of 671,313. The company's fifty day simple moving average is $5.21 and its two-hundred day simple moving average is $5.75. Quanterix Corporation has a twelve month low of $4.05 and a twelve month high of $15.85. The stock has a market cap of $223.52 million, a P/E ratio of -2.64 and a beta of 1.03.

Quanterix (NASDAQ:QTRX - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.47) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.06). The business had revenue of $24.48 million during the quarter, compared to analyst estimates of $29.73 million. Quanterix had a negative return on equity of 18.41% and a negative net margin of 56.04%. Quanterix has set its FY 2025 guidance at EPS. Sell-side analysts expect that Quanterix Corporation will post -0.98 EPS for the current fiscal year.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.